EDGAR Filing Documents for 0000899243-17-016988

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000899243-17-016988

Filing Date

2017-06-22

Accepted

2017-06-22 21:38:57

Documents

Period of Report

2017-06-01

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	8247
	Complete submission text file	0000899243-17-016988.txt		9656

Mailing Address PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address

Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 17926243

Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080

Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700

Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations